HealthEquity, Inc. (NASDAQ:HQY) Position Decreased by Overbrook Management Corp

Overbrook Management Corp decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 48.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 73,544 shares of the company's stock after selling 68,957 shares during the period. HealthEquity makes up 1.4% of Overbrook Management Corp's portfolio, making the stock its 26th biggest holding. Overbrook Management Corp owned 0.08% of HealthEquity worth $6,020,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in HQY. International Assets Investment Management LLC acquired a new position in shares of HealthEquity in the second quarter worth about $35,000. Paladin Wealth LLC acquired a new stake in shares of HealthEquity during the third quarter worth approximately $39,000. GAMMA Investing LLC boosted its holdings in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock worth $51,000 after purchasing an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of HealthEquity during the second quarter worth approximately $73,000. Finally, 1620 Investment Advisors Inc. acquired a new stake in shares of HealthEquity during the third quarter worth approximately $112,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on HQY. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 price target for the company. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Barrington Research reaffirmed an "outperform" rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Bank of America raised their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research report on Wednesday, November 13th. Finally, BTIG Research raised their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $107.23.

HealthEquity Price Performance

NASDAQ:HQY opened at $102.96 on Thursday. HealthEquity, Inc. has a one year low of $62.10 and a one year high of $103.69. The stock has a market cap of $8.99 billion, a P/E ratio of 85.80, a PEG ratio of 1.61 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The company has a fifty day moving average price of $86.66 and a 200 day moving average price of $81.57.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The company had revenue of $299.93 million during the quarter, compared to analysts' expectations of $284.48 million. Analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Insider Activity

In related news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now owns 3,784 shares of the company's stock, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is currently owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.